Geron Corp (GERN) stock
Close on Nov 17, 2026Market cap $642.47MP/E –Yield –
Earnings
Geron's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Geron's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 24, 2027Expected | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Nov 4, 2026before the open | $60.10M | +27.3% | $0.00 | Release |
| Q2 FY2026ended Jun 30, 2026 | Aug 6, 2026before the open | $57.48M | +17.3% | -$0.02 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 25, 2026before the open | $48.00M | +1.1% | -$0.05 | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 5, 2025before the open | $47.20M | +66.8% | – | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 6, 2025before the open | $49.00M | +5455.6% | -$0.02 | Release |
| Q1 FY2025ended Mar 31, 2025 | May 7, 2025before the open | $39.60M | +12926.3% | -$0.03 | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 26, 2025before the open | $47.50M | +206421.7% | -$0.04 | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 7, 2024before the open | $28.30M | +17156.1% | -$0.04 | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 8, 2024before the open | $882.00K | +2941.4% | -$0.10 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 2, 2024before the open | $304.00K | – | -$0.09 | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 28, 2024before the open | $23.00K | -77.7% | -$0.09 | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 2, 2023before the open | $164.00K | -44.8% | -$0.08 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 3, 2023after the close | $29.00K | -60.3% | -$0.09 | Release |
| Q1 FY2023ended Mar 31, 2023 | Apr 20, 2023during market hours | – | – | – | Release |
| Q4 FY2022ended Dec 31, 2022 | Mar 16, 2023after the close | $103.00K | -89.7% | -$0.10 | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 3, 2022before the open | $297.00K | +172.5% | -$0.10 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 11, 2022after the close | $73.00K | – | -$0.07 | Release |
| Q1 FY2022ended Mar 31, 2022 | Apr 13, 2022before the open | – | – | – | Release |
| Q4 FY2021ended Dec 31, 2021 | Mar 10, 2022after the close | $1.00M | – | -$0.10 | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 10, 2021after the close | $109.00K | – | -$0.08 | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 16, 2021after the close | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | May 10, 2021after the close | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Mar 11, 2021after the close | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Nov 5, 2020after the close | – | – | – | Filing |
| Q2 FY2020ended Jun 30, 2020 | Aug 6, 2020after the close | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Geron's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| RYTELO net product revenue | FY2026 | $220.00M – $240.00M | – | New | Nov 4, 2026 |
| RYTELO net product revenue | FY2026 | $220.00M – $240.00M | $220.00M – $240.00M | Reaffirmed | Aug 6, 2026 |
| total operating expenses | FY2026 | $220.00M – $230.00M | – | New | Nov 4, 2026 |
| total operating expenses | FY2026 | $230.00M – $240.00M | $230.00M – $240.00M | Reaffirmed | Aug 6, 2026 |
Guidance vs results
The last range Geron gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| Q4 FY2024 | Revenue | $45.00M – $46.00M | $47.50M | Above range |
Guidance history
Every forecast Geron put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Nov 4, 2026 | total operating expenses | FY2026 | $220.00M – $230.00M | New |
| Nov 4, 2026 | RYTELO net product revenue | FY2026 | $220.00M – $240.00M | New |
| Aug 6, 2026 | total operating expenses | FY2026 | $230.00M – $240.00M | Reaffirmed |
| Aug 6, 2026 | RYTELO net product revenue | FY2026 | $220.00M – $240.00M | Reaffirmed |
| Feb 25, 2026 | total operating expenses | FY2026 | $230.00M – $240.00M | New |
| Feb 25, 2026 | RYTELO net product revenue | FY2026 | $220.00M – $240.00M | New |
| Nov 5, 2025 | total operating expenses | FY2025 | $250.00M – $260.00M | Lowered |
| Aug 6, 2025 | total operating expenses | FY2025 | $270.00M – $285.00M | New |
| May 7, 2025 | total operating expenses | FY2025 | $270.00M – $285.00M | New |
| Feb 26, 2025 | total operating expenses | FY2025 | $270.00M – $285.00M | Reaffirmed |
| Jan 13, 2025 | expected OpEx range | FY2024 | $250.00M – $260.00M | Lowered |
| Jan 13, 2025 | expected OpEx range | FY2025 | $270.00M – $285.00M | New |
| Jan 13, 2025 | estimated net revenues | Q4 FY2024 | $45.00M – $46.00M | New |
| Nov 7, 2024 | total operating expenses | FY2024 | $260.00M – $270.00M | Lowered |
| Aug 8, 2024 | total operating expenses | FY2024 | $270.00M – $280.00M | New |
| May 2, 2024 | employees | FY2024 | 250 – 300 | Raised |
| May 2, 2024 | total operating expenses | FY2024 | $270.00M – $280.00M | Reaffirmed |
| Feb 28, 2024 | employees | FY2024 | 270 | New |
| Feb 28, 2024 | total operating expenses | FY2024 | $270.00M – $280.00M | New |
| Nov 2, 2023 | employees | FY2023 | 160 | Raised |
| Nov 2, 2023 | total expenses | FY2023 | $200.00M – $210.00M | Lowered |
| Aug 3, 2023 | employees | FY2023 | 150 – 160 | New |
| Aug 3, 2023 | total expenses | FY2023 | $210.00M – $220.00M | Reaffirmed |
| Aug 3, 2023 | non-GAAP total expenses | FY2023 | $200.00M – $210.00M | Reaffirmed |
| Mar 16, 2023 | total expenses | FY2023 | $210.00M – $220.00M | New |
| Mar 16, 2023 | non-GAAP total expenses | FY2023 | $200.00M – $210.00M | New |
| Nov 3, 2022 | total operating expenses | FY2022 | $155.00M – $165.00M | Reaffirmed |
| Nov 3, 2022 | non-GAAP total operating expenses | FY2022 | $140.00M – $150.00M | Reaffirmed |
| Aug 11, 2022 | total operating expenses | FY2022 | $155.00M – $165.00M | Reaffirmed |
| Aug 11, 2022 | non-GAAP total operating expenses | FY2022 | $140.00M – $150.00M | Reaffirmed |
| Mar 10, 2022 | total operating expenses | FY2022 | $155.00M – $165.00M | New |
| Mar 10, 2022 | non-GAAP total operating expenses | FY2022 | $140.00M – $150.00M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Geron filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- News
- Results
- Results
- Update
- Update
- Results
- Update
- Results
- Results
- Results
- Results
- Results
- Geron Corporation Announces Up to $375 Million in Funding with Royalty Pharma and Pharmakon AdvisorsResults
- Results
See a number that looks wrong?